Angiotensin II receptor / Calcium channel / HMG-CoA reductase drugs for Atherosclerotic Cardiovascular Disease

2 tracked Angiotensin II receptor / Calcium channel / HMG-CoA reductase drugs in the Atherosclerotic Cardiovascular Disease race. The class explanation lives on the Angiotensin II receptor / Calcium channel / HMG-CoA reductase page; the full indication pipeline across every mechanism is on the Atherosclerotic Cardiovascular Disease page.

1 Phase 31 preclinical / unstaged

Head-to-head evidence: Amlodipine/valsartan/atorvastatin (CJ-30061) vs OLOMAX

The roster

← all Angiotensin II receptor / Calcium channel / HMG-CoA reductase drugs